Science Explorer Back to mapMap
Discussion
Researcher · National Hospital Abuja · Nigeria

Festus Igbinoba

Festus Igbinoba publishes mostly in Oncology, Epidemiology and Cancer Research, on topics such as Cervical Cancer and HPV Research, Global Cancer Incidence and Screening and Viral-associated cancers and disorders.

ORCID 0000-0001-5148-9932 OpenAlex
World rank
#2,624,474
of 7,710,434 ranked researchers
Rank in Nigeria
#3,575
of 26,141
Works
78
Citations
1k
Citations per work
12.9
h-index
11
i10-index 11Top 54% in Oncology
Festus Igbinoba

What does Festus Igbinoba research?

Festus Igbinoba's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 47 works · 60.3% of their workMedicine: 47 works · 60.3% of their workOncology: 25 works · 31.5% of their workEpidemiology: 14 works · 17.8% of their workOtorhinolaryngology: 4 works · 5.5% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 5.5% of their workEverything else: 25 works · 31.5% of their workLife Sciences: 6 works · 8.2% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 8.2% of their workCancer Research: 4 works · 5.5% of their workMolecular Biology: 2 works · 2.7% of their workTHEIR WORKFestus Igbinoba78works
Life Sciences8%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4760.3%
  2. Everything else2531.5%
    1. Biochemistry, Genetics and Molecular Biology68.2%
  1. 1Oncology32% of their works
  2. 2Epidemiology18% of their works
  3. 3Cancer Research6% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Otorhinolaryngology6% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Festus Igbinoba's research?

The keywords of their largest research topics: Cancer Incidence, Human Papillomavirus, Cervical Cancer, HPV Vaccination, Global Surveillance, Mortality Rates, Radiotherapy and Chemotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Cancer Incidence253 topics
  2. Human Papillomavirus152 topics
  3. Cervical Cancer111 topic
  4. HPV Vaccination111 topic
  5. Global Surveillance101 topic
  6. Mortality Rates101 topic
  7. Radiotherapy93 topics
  8. Chemotherapy72 topics
  9. Survival72 topics
  10. Cancer Treatment41 topic
  11. Epstein-Barr Virus41 topic
  12. Global Access41 topic
  13. Kaposi's Sarcoma41 topic
  14. Oropharyngeal Cancer41 topic
  15. Squamous Cell Carcinoma41 topic
  16. Cancer31 topic
  17. Obesity31 topic
  18. Breast Tumours11 topic
  19. Cancer Genomics11 topic
  20. Gene Expression11 topic
  21. Mutational Signatures11 topic

Where does Festus Igbinoba work?

Festus Igbinoba's main affiliation in the publication record is National Hospital Abuja, Nigeria.

How many publications and citations does Festus Igbinoba have?

OpenAlex counts 78 works and 1,010 citations for Festus Igbinoba, an h-index of 11, ranking #2,624,474 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Festus Igbinoba. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.